Phillips-Medisize A/S: Financial statements 2025
CVR: 24053415
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Phillips-Medisize A/S (CVR 24053415) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 425,791,000 and a net result of DKK 35,364,000 compared with DKK 12,144,000 the year before. The profit margin was 8.3%. Equity in the 2025 report amounted to DKK 148,900,000. The solvency ratio was 75%. The company had 229 employees in the financial year.
- Revenue
- DKK 425,791,000
- Gross Profit
- DKK 100,350,000
- Profit/Loss
- DKK 35,364,000
- Equity
- DKK 148,900,000
- Total Assets
- DKK 198,472,000
- Employees
- 229
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 425.8 mio. | 100.3 mio. | 35.4 mio. | 148.9 mio. | 229 |
| 2024 | 425.6 mio. | 72.8 mio. | 12.1 mio. | 113.5 mio. | - |
| 2023 | 481.9 mio. | 171 mio. | 83.4 mio. | 241.4 mio. | - |
| 2022 | 378 mio. | 91.8 mio. | 49 mio. | 158 mio. | 217 |
| 2021 | 360.6 mio. | 80.8 mio. | 36.9 mio. | 108.8 mio. | - |
Official annual report
How creditworthy is Phillips-Medisize A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Phillips-Medisize A/S has published its annual report for 2024. Revenue came to DKK 425,551,000, and the net result was DKK 12,144,000.
About Phillips-Medisize A/S
Phillips-Medisize A/S is a Danish company of the type Aktieselskab based in Struer, founded in 1930. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Medicom Innovation Partner a/s and BANG & OLUFSEN MEDICOM A/S. The management consists of Cecilie Rørbye. The board consists of David William Cole (chair), Brett Alan Landrum and Nitesh Gupta. The company is owned by Phillips-Medisize Holdings A/S. The company has 228 employees (2026). In 2025, the company reported revenue of DKK 425,791,000 and a net result of DKK 35,364,000 compared with DKK 12,144,000 the year before. Equity in the 2025 report amounted to DKK 148,900,000.